Prempro News |
| |
We have compiled the latest news on Prempro. If you or a loved one has been harmed by Prempro and you would like more information about
your legal rights, please contact us. |
 |
|
Pfizer Inc. agreed to settle an Arkansas woman's claims that the company's Prempro menopause drug caused her breast cancer, avoiding a second punitive damages trial in the case, according to a court filing.
New York-based Pfizer faced an Oct. 1 retrial of Donna Scroggin's claims that the world's largest drugmaker should pay millions of dollars as punishment for mishandling its Prempro hormone-replacement medicine, according to court records. An appeals court overturned a $27.1 million punitive award last year and ordered a new trial on damages.
The company agreed to settle Scroggin's case, U.S. District Judge William Wilson said in an Aug. 19 court filing. Wilson is overseeing more than 8,000 cases involving the medicine, consolidated in federal court in Arkansas. Terms of the settlement weren't disclosed in the filing |
| |
|
A lawsuit filed by the Nevada attorney general claiming pharmaceutical giants Wyeth, Pfizer and Upjohn misled the public about the safety of their hormone therapy drugs must be heard in state court, not federal court, a federal judge has ruled.
The order is considered a win for the state, which filed suit in November, claiming the firms violated the Nevada Deceptive Trade Practices Act in the promotion and sale of drugs used to offset the effects of menopause. |
| |
|
Researchers looking into the long-term health effects of hormone replacement therapy said on Wednesday they had made the strongest case yet that the pills raise the risk of breast cancer. |
 |
|
Sen. Charles Grassley’s investigation of whether Wyeth hired ghostwriters to pen articles for medical journals has prompted a major medical publisher, Elsevier, to look into the matter itself.
Elsevier publishes the American Journal of Obstetrics and Gynecology, in which an “Editor’s Choice” article in May 2003 discussed the Women’s Health Initiative, a major study that was halted when researchers saw a higher risk for breast cancer among women taking Wyeth’s hormone-replacement therapy Prempro. |
| |
|
Elsevier, a medical publisher, said Friday that it would investigate a senator’s recent allegation that one of its journals published an article on hormone replacement therapy that was improperly ghostwritten by a drug company promoting the product. |
| |
|
Wyeth, the pharmaceutical company, paid ghostwriters to produce medical journal articles favorable to its hormone replacement therapy Prempro, according to Congressional letters seeking more information about the company’s involvement in medical ghostwriting. At least one article was published even after a federal study found the drug raised the risk of breast cancer.
The letters, sent electronically Friday by Senator Charles E. Grassley, ask Wyeth and DesignWrite, a medical writing company, to disclose payments related to the preparation of journal articles and the activities of doctors who were recruited to put their names on them for publication. |
| |
|
Nevada Attorney General Catherine Cortez Masto filed suit today against Wyeth and Pfizer, two leading manufacturers of hormone therapy drugs commonly prescribed to women after menopause.
The suit alleges that Wyeth's sale of Premarin, Prempro and Premphase, and Pfizer's sale of Provera, involved deceptive trade practices which misled Nevada consumers and physicians about the safety and efficacy of these drugs.
The suit contends that Wyeth and Pfizer intentionally minimized the risks and exaggerated the benefits of taking their hormone therapy drugs, resulting in over-prescribing and a dramatic increase in hormone-positive breast cancers in women after menopause. |
 |
|
A jury has levied a $134.5 million judgment against the pharmaceutical maker Wyeth in a lawsuit filed by three Nevada women who contended that the company's hormone-replacement drugs had caused their breast cancer.
It was the largest award to date against Wyeth, of Madison, N.J., which faces more than 5,000 similar lawsuits against the country in state and federal courts. |
|
 |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424
800.883.8888
info@vanosteen.com
|
Your Legal Rights |
If you have been diagnosed with breast cancer following use of Prempro, Premarin or Provera, you may be entitled
to compensation.
You
should act immediately to contact a lawyer experienced in matters involving defective pharmaceuticals.
|
 |
Contact Us |
|
|
